Perhaps timely catching Legend Biotech Corp ADR (LEGN) would be a good idea

With 0.66 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.98 million shares. The 52-week range on LEGN shows that it touched its highest point at $77.32 and its lowest point at $44.52 during that stretch. It currently has a 1-year price target of $86.42. Beta for the stock currently stands at 0.02.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of LEGN was down-trending over the past week, with a drop of -3.69%, but this was down by -17.25% over a month. Three-month performance dropped to -4.45% while six-month performance fell -17.51%. The stock gained 19.82% in the past year, while it has lost -6.78% so far this year. A look at the trailing 12-month EPS for LEGN yields -2.95 with Next year EPS estimates of -0.22. For the next quarter, that number is -0.18. This implies an EPS growth rate of 22.42% for this year and 80.48% for next year.

Float and Shares Shorts:

At present, 181.91 million LEGN shares are outstanding with a float of 180.13 million shares on hand for trading. On Mar 15, 2024, short shares totaled 10.51 million, which was 5.78% higher than short shares on Feb 15, 2024. In addition to VEGN as the firm’s VEGN, REGN serves as its Regeneron Pharmaceuticals, Inc.

Institutional Ownership:

Through their ownership of 48.71% of LEGN’s outstanding shares, institutional investors have minority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for LEGN since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, LEGN has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and LEGN currently yields $0.00. In the past year, LEGN’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, LEGN has a current buyback yield of $––. This was $–– for the TTM, and it was $–– for the past five years.